Glow Blend 70mg Research Peptides
Glow Blend — USA Made, ≥99% Purity
4.9 177 verified reviews- 70mg three-component blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
- USA manufactured in GMP-certified California and Arizona laboratory facilities
- ≥99% component purity target with HPLC, mass spectrometry, and combined batch COA
For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.
Specifications
Lot GL342- CAS
- GHK-Cu: 89030-95-5; BPC-157: 137525-51-0; TB-500: 885340-08-9
- Molecular mass
- GHK-Cu: 402.92 g/mol; BPC-157: 1,419.5 g/mol; TB-500: 889.01 g/mol
- Purity target
- ≥99% per peptide component (3rd-Party HPLC Tested)
- Form
- Lyophilized Powder
- Origin
- Manufactured, Formulated & Packaged in CA/AZ, USA
- Storage
- Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light
What is Glow Blend?
Glow Blend is a 70mg multi-peptide research formulation containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg. It combines a copper tripeptide, a 15-residue peptide, and the seven-residue Ac-LKKTETQ fragment in one lyophilized vial.
Each ingredient keeps its own chemical identity after blending. The formulation allows researchers to investigate copper coordination, extracellular-matrix signaling, vascular pathways, and actin-related cell behavior within a single controlled design.
How It Works
GHK-Cu: Coordinates copper and is studied in fibroblast, gene-expression, and extracellular-matrix remodeling models.
BPC-157: Preclinical work examines VEGFR2, Akt/eNOS, nitric-oxide, and cell-migration signaling.
TB-500: Ac-LKKTETQ represents a thymosin beta-4 actin-binding region studied in cytoskeletal and motility research.
Every lot, on the record
Independent third-party HPLC evaluates the purity target, while mass spectrometry confirms molecular identity. Both results are documented in one combined, batch-specific Certificate of Analysis.
- Identity (LC-MS)
- Confirmed
- Appearance
- Blue Lyophilized Powder
| Analyte | Method | Specification | Result | Pass/fail |
|---|---|---|---|---|
| Identity | LC-MS | GHK-Cu/Thymosin Beta-4/BPC-157 | ||
| Purity | HPLC-UV | 99.76% | ||
| Net Content | GHK-Cu - 56.40 mg, BPC-157 - 10.26 mg, Thymosin Beta-4 - 10.74 mg |
Chromatogram
Mass confirmation
Why Source from 321 Peptides?
Lot history 4 released lots
Every batch released under this compound, with the figure reported for each.
| Lot | Reported | Purity | Net content | COA |
|---|---|---|---|---|
| GL342 | 2026-06-01 | 99.76% | GHK-Cu - 56.40 mg, BPC-157 - 10.26 mg, Thymosin Beta-4 - 10.74 mg | |
| GL-49504 Superseded | 2026-05-06 | 99.46% | 70.49 mg | Pending |
| GL-50081 Superseded | 2026-05-02 | 99.58% | 70.56 mg | Pending |
| GL-48927 Superseded | 2026-04-08 | 99.49% | 70.42 mg | Pending |